DRUG DISCOVERY SOLUTIONS LIMITED

Active Loughborough

Management consultancy activities other than financial management

3 employees website.com
Life sciences and medical technology Management consultancy activities other than financial management
D

DRUG DISCOVERY SOLUTIONS LIMITED

Management consultancy activities other than financial management

Founded 4 Jul 2022 Active Loughborough, England 3 employees website.com
Life sciences and medical technology Management consultancy activities other than financial management
Accounts Submitted 6 Oct 2025 Next due 30 Apr 2027 12 months remaining
Confirmation Submitted 7 Jul 2025 Next due 17 Jul 2026 2 months remaining
Net assets £19K £10K 2025 year on year
Total assets £55K £38K 2025 year on year
Total Liabilities £36K £29K 2025 year on year
Charges None No charges registered

Contact & Details

Contact

Registered Address

3 Japonica Close Loughborough Leicestershire LE11 2SB England

Website

www.example.com

Full company profile for DRUG DISCOVERY SOLUTIONS LIMITED (14211599), an active life sciences and medical technology company based in Loughborough, England. Incorporated 4 Jul 2022. Management consultancy activities other than financial management. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2025
Type Total Exemption Full
Next accounts 31 December 2026
Due by 30 September 2027 9 months

Net Assets, Total Assets & Total Liabilities (2023–2025)

Cash in Bank

N/A

Net Assets

£19.21k

Increased by £9.88k (+106%)

Total Liabilities

£35.71k

Increased by £28.61k (+403%)

Turnover

N/A

Employees

3

Increased by 1 (+50%)

Debt Ratio

65%

Increased by 22 (+51%)

Financial History

Revenue, profit, EBITDA and key financial figures

2025
Dec Year End
2024
Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Officers

Officers

1 active
Status
Richard WeaverDirectorBritishEngland564 Jul 2022Active

Shareholders

Shareholders (2)

Richard Weaver
75.0%
Amy Clare Weaver
25.0%

Persons with Significant Control

Persons with Significant Control (1)

1 Active

Richard Weaver

British

Active
Notified 4 Jul 2022
Residence England
DOB October 1969
Nature of Control
  • Ownership Of Shares 50 To 75 Percent

Group Structure

Group Structure

No group structure identified

Charges

Charges

No charges registered

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
26 Feb 2026IncorporationMemorandum Articles
26 Feb 2026CapitalCapital Name Of Class Of Shares
26 Feb 2026ResolutionResolutions
6 Oct 2025AccountsAnnual accounts made up to 31 Jul 2025
7 Jul 2025Confirmation StatementConfirmation statement made on 3 Jul 2025 with updates
26 Feb 2026 Incorporation

Memorandum Articles

26 Feb 2026 Capital

Capital Name Of Class Of Shares

26 Feb 2026 Resolution

Resolutions

6 Oct 2025 Accounts

Annual accounts made up to 31 Jul 2025

7 Jul 2025 Confirmation Statement

Confirmation statement made on 3 Jul 2025 with updates

Recent Activity

Latest Activity

Memorandum Articles

2 months ago on 26 Feb 2026

Capital Name Of Class Of Shares

2 months ago on 26 Feb 2026

Resolutions

2 months ago on 26 Feb 2026

Annual accounts made up to 31 Jul 2025

6 months ago on 6 Oct 2025

Confirmation statement made on 3 Jul 2025 with updates

9 months ago on 7 Jul 2025